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Objective: Providers’ use of clinical evidence technologies (CETs) improves their diagnosis and treatment 
decisions. Despite these benefits, few studies have evaluated the impact of CETs on patient outcomes. The 
investigators evaluated the effect of one CET, VisualDx, on skin problem outcomes in primary care. 
Methods: A cluster-randomized controlled pragmatic trial was conducted in outpatient clinics at an academic 
medical center in the northeastern United States. Participants were primary care providers (PCPs) and their 
adult patients seen for skin problems. The intervention was VisualDx, as used by PCPs. Outcomes were 
patient-reported time from index clinic visit to problem resolution, and the number of follow-up visits to any 
provider for the same problem. PCPs who were randomly assigned to the intervention agreed to use VisualDx 
as their primary evidence source for skin problems. Control group PCPs agreed not to use VisualDx. 
Investigators collected outcome data from patients by phone at thirty-day intervals. Cox proportional hazards 
models assessed time to resolution. Wilcoxon-rank sum tests and logistic regression compared the need for 
return appointments. 
Results: Thirty-two PCPs and 433 patients participated. In proportional hazards modelling adjusted for 
provider clusters, the time from index visit to skin problem resolution was similar in both groups (hazard 
ratio=0.92; 95% confidence interval [CI]=0.70, 1.21; p=0.54). Patient follow-up appointments did not differ 
significantly between groups (odds ratio=1.26; CI=0.94, 1.70; p=0.29). 
Conclusion: This pragmatic trial tested the effectiveness of VisualDx on patient-reported skin disease 
outcomes in a generalizable clinical setting. There was no difference in skin problem resolution or number of 
follow-up visits when PCPs used VisualDx. 
 
INTRODUCTION 
Health care providers across a spectrum of primary 
care and specialty domains regularly refer to clinical 
evidence technologies (CETs) to answer clinical 
questions [1]. As reported in provider survey and 
chart review studies, use of CETs such as 
PubMed/MEDLINE, journal articles, electronic 
texts, topic summaries, and Internet search engines 
has improved diagnosis and treatment decisions and 
avoided adverse events [2–6]. Despite these provider 
reports, few studies have evaluated the impact of 
CETs on patient-level outcomes. Patient-level 
outcomes include mortality, relief of symptoms, 
impact on activity, perceived benefit, and costs to 
the patient, such as length of hospital stay and lost 
work time [7]. The literature on patient outcomes of 
CET use is mixed. Only one published study has 
reported an improvement in patient outcomes. 
Researchers reviewed insurance claims from 
hospitals before and after subscribing to UpToDate 
(a source for comprehensive medical topic 
summaries). Results showed a modest reduction in 
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morbidity and length of stay in hospitals after 
subscribing [8]. 
Hospital libraries and informatics centers 
acquire and make CETs available to the clinical 
community on the assumption that these resources 
have value for education, practice improvement, 
and outcomes of care. CET licenses can be 
expensive. Medical school libraries associated with 
teaching hospitals in the United States or Canada 
spent an average of US$2 million each in 2015 for 
medical research journals and clinical information 
resources [9]. While CETs, individually or in 
combination, have been evaluated for education and 
practice-level outcomes, they have not undergone 
rigorous evaluations with randomized trials for 
patient outcomes. A 2015 systematic review of 
electronic health information, including CETs, found 
no randomized trials with patient outcomes, such as 
utilization or relief from symptoms [10]. 
The broad nature and diverse goals of many 
CETs may discourage rigorous evaluation. 
However, skin conditions are a relatively 
circumscribed domain within the broad field of 
primary care. The clinical goal in many cases can be 
quantified as time-to-problem resolution. Likewise, 
the need for additional medical care after the index 
visit usually represents a suboptimal and expensive 
outcome that might be reduced by improved 
provider knowledge and decision support [11]. 
Skin problems account for 15% of primary care 
office visits in the United States [12], and 10 common 
dermatologic conditions (dermatitis, pyoderma, 
tinea, benign neoplasms, candida, dermatosis, warts, 
malignant neoplasm, sebaceous cyst, and acne) 
account for 77% of skin-related diagnoses in family 
practices. Likewise, many internal conditions 
manifest themselves on the skin, including 
malignancies, vascular conditions, anemia, 
endocrine disorders, and pregnancy. Most skin 
conditions first present, and are often diagnosed and 
managed, in primary care. Eight percent of all 
outpatient visits for skin problems result in referrals 
to dermatologists or return visits to primary care 
[13]. Limitations in the ability of primary care 
providers (PCPs) to diagnose skin rashes and lesions 
correctly have been noted in the literature [14, 15]. 
Some studies indicate that additional dermatology 
knowledge, training, and diagnostic support could 
improve practice and patient outcomes. General 
practitioners in the United Kingdom who used an 
online source for skin cancer diagnosis information 
increased their diagnostic accuracy and confidence, 
but referrals were not reduced [16]. Referrals to 
dermatology in a Veterans Affairs hospital that 
lacked a specific diagnosis were reduced by an 
intervention that trained PCPs [17]. 
VisualDx is a CET that presents images and text 
on a comprehensive range of skin conditions and 
symptoms that are local to the skin or manifestations 
of internal conditions [18]. Users can search by 
diagnosis or by patient characteristics and 
examination findings to generate a differential 
diagnosis list with images. Individuals, practices, 
and institutions license VisualDx to support medical 
education and patient care [19]. VisualDx has been 
shown to improve diagnostic competency in non–
primary care settings. In one study, its use improved 
the differential diagnosis of cellulitis by emergency 
room physicians [20]. In a pilot study, diagnostic 
accuracy of dermatology residents and medical 
students increased after using VisualDx, as judged 
by a consultant dermatologist [21]. 
Given the prevalence and broad range of skin 
conditions seen in primary care, the need for PCPs’ 
improved knowledge and competency in skin 
disease, the availability of a dermatology-focused 
CET (i.e., VisualDx) that has been shown to affect 
clinical competence, and the lack of randomized 
clinical trials of any CET with patient-level 
outcomes, the authors proposed a clinical trial to 
evaluate use of VisualDx in primary care in the 
domain of skin disease with patient-level outcomes. 
Our objective was to evaluate the effect of 
VisualDx on duration of symptoms and follow-up 
care for skin problems in a pragmatic randomized 
clinical trial in primary care. Recognizing that in 
typical clinical care, the correct diagnosis and 
therapy are often uncertain, that some problems 
resolve regardless of whether the management was 
technically correct, and that some resist even the 
most insightful management, we were concerned in 
this study with the net result of each episode of 
care—the patient outcomes—rather than the 
intermediate steps of management (i.e., diagnosis or 
treatment decisions). 
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METHODS 
Study design, model, and setting 
We designed a cluster-randomized controlled trial to 
evaluate the outcomes of skin problems for patients 
whose PCP referred to VisualDx or not (usual care). 
In this design, PCPs were the subjects of 
randomization. Patients were clustered in the arm of 
the provider they saw for the skin problem. The 
cluster design was appropriate because the 
intervention was directed to physicians, while the 
outcomes occur in individual patients [22]. With 
randomization, environmental and provider or 
subject characteristics (e.g., years in practice, 
insurance status, chronicity of the presenting 
complaint, comorbidities) were distributed at chance 
levels across both arms of the experiment. 
The model underlying the design of the 
experiment asserted that the CET supported PCPs in 
management (i.e., diagnosis, treatment, and referral 
decisions) and impacts patient-level outcomes—
resolution of symptoms and return appointments—
when used in a real-world clinical setting. 
Presumably, use of a valuable CET leads to more 
correct diagnoses and wiser therapeutic or referral 
choices. These, in turn, lead to better patient 
outcomes (i.e., quicker resolution of the presenting 
problem or reduced need for additional care). To test 
this model, we performed a pragmatic [23] (i.e., not 
heavily controlled) cluster-randomized controlled 
trial of the impact of one CET on the outcomes of 
skin problems presenting to primary care (Figure 1). 
The study was conducted at clinics associated 
with an academic regional medical center in the 
northeast United States. VisualDx and other CETs 
were available to medical center clinicians through 
the hospital intranet, electronic health record, and 
mobile devices. The institutional review board 
approved the protocol in June 2015. 
Provider subjects 
Attending physicians, residents, advanced practice 
nurses, and physician assistants in outpatient family 
medicine and general internal medicine were invited 
to participate by email or personal contact. Eligible 
providers (1) were currently seeing patients at a 
primary care site, (2) consented and agreed to 
comply with the protocol procedures assigned, and 
(3) permitted patients to be informed of the study 
via a letter sent over their signature. Providers 
answered a survey concerning resident or attending 
status, year of clinical degree, sex, specialty, and 
typical number of times per month that they used 
CETs for patient care (supplemental Appendix A). 
We randomly assigned PCPs to intervention or 
control groups using a sequential numbered 
envelope method, stratified by resident status [24]. 
We randomized residents independently because of 
the possibility that they might respond differently to 
the intervention than more experienced providers 
would. PCPs were enrolled in the study when they 
gave consent, completed the tutorial, provided their 
signature for patient letters, and affirmed their 
agreement to follow their assigned protocol. 
Figure 1 Model of the cluster-randomized pragmatic design 
 
PCP=primary care provider; CET=clinical evidence technology. 
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Patient subjects 
Adult patients seen for acute or chronic skin 
problems, excluding lacerations or burns, were 
eligible. Patients were excluded if they did not speak 
English or were decisionally impaired. To identify 
patients, we reviewed the appointment records of 
participating providers for patients who were seen 
for a skin problem. We identified patients with any 
complaint in the broad range of skin diseases as 
noted in the electronic health record. The reason for 
visit, appointment note, and clinical summary fields 
provided information about patient complaints, 
such as “rash,” “redness,” “lump,” “itch,” “wart,” 
“mole,” or “sore.” International Classification of 
Diseases codes were also used to identify potential 
cases. Per the institutionally approved protocol, 
personal health information from the patient 
record—such as reason for visit, phone number, and 
address—could be used for identification and 
recruitment but not to ascertain patient 
characteristics or outcomes. 
We sent each identified patient a letter signed by 
their PCP describing the study and informing them 
that the study team would call to invite their 
participation. The letter also stated how to opt out of 
any contact. 
Intervention 
The intervention was VisualDx, as used by PCPs 
treating patients with skin problems. Providers 
received email notification of their experimental 
group status with a link to a self-paced slide tutorial 
that was specific to their group (supplemental 
Appendixes B and C). For the “Active” group, the 
five-to-ten-minute tutorial included the direction to 
use VisualDx when needed in treating a patient skin 
problem and instructions on how to access and use 
the CET. For the “Control” group, the tutorial 
included the direction not to use VisualDx and a 
general orientation to information sources that are 
available through the medical library. A study team 
member contacted participating providers by email, 
phone, and letter at intervals during the study to 
remind them of their assigned protocol and to 
confirm their continued participation. 
Measurements 
The primary predictor (i.e., independent variable) 
was the randomized group status of the provider: 
Active (use of VisualDx) or Control (non-use). 
Patient subjects were assigned to the group of the 
provider they saw. The primary outcome variables 
reported by the patients were (1) time to resolution 
of the skin problem from presentation at the primary 
care office visit and (2) number of follow up visits 
(to any provider) for the same problem. 
About thirty days after the index visit, an 
investigator phoned each eligible patient (except 
those who had opted out) and, following verbal 
consent, proceeded with interview questions. If the 
patient reported their presenting skin problem 
resolved (i.e., “all better”), their participation in the 
study was concluded. Patients whose presenting 
complaint had not resolved were reinterviewed at 
sixty days and, if still unresolved, again at ninety 
days. The thirty-sixty-ninety day phone call 
schedule was specified in the protocol to balance the 
requirements to reach many people while 
preserving patient recall [25]. 
At the first interview, patients reported their 
ages, sexes, and whether the PCP seen was their 
usual provider (supplemental Appendix D). We 
ascertained the status of the skin problem as “all 
better,” “improved,” “unchanged,” or “worse” each 
time that we interviewed the patient. If it was “all 
better” at any interview, we asked them to recall the 
number of days from the index visit date or the date 
when they realized the problem was resolved. If 
necessary, we asked questions to aid more exact 
recall. This determined the “days to resolution” 
outcome variable. The final problem status at the 
last completed interview was determined for 
analysis. 
To determine the number of follow-up 
appointments, at the first interview, we asked how 
many appointments the patient had had for the 
same problem since the index visit. If there was a 
second or third phone interview, we asked how 
many appointments they had had since the last call 
and added that number to any previously reported 
appointments, if any. The total number of 
appointments reported constituted the variable. 
Data collection 
Trained research assistants using standardized 
scripts conducted patient interviews by phone. 
Study data were collected and managed using 
Research Electronic Data Capture (REDCap) secure 
tools, hosted by the researchers’ institution. 
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Blinding 
By necessity, providers knew their own intervention 
or control group status. Investigators were blind to 
providers’ and patients’ groups while conducting 
patient interviews. Patients were blind to the group 
assignment of their providers. 
Analysis 
We used Cox proportional hazards models to assess 
time to resolution and Wilcoxon-rank sum tests and 
logistic regression to compare return appointments 
between groups. Logistic and proportional hazards 
models were adjusted for clustering. Data analyses 
were performed using Stata 14 statistical software. 
We sought an adequate sample size to detect a 
moderate-to-large effect of the intervention, on the 
order of 0.4 standard deviations. Given the broad 
range of skin problems presenting in primary care, 
we expected significant variability in the time to 
resolution. Therefore, we chose a target of 8 days to 
resolution with a standard deviation of 20 days. The 
effect of clustering with PCP was not known, but we 
used estimates from other primary care settings that 
suggested an intra-cluster correlation of 
approximately 0.025 [26]. Assuming α=0.05, β=0.80, 
10 patients per provider, and a 2-sided t-test, we 
estimated the study needed 26 PCPs and 260 
patients. 
RESULTS 
We enrolled 31 physicians and 1 nurse practitioner. 
We identified 989 eligible patients with a visit to a 
participating PCP related to a skin problem between 
November 2015 and August 2016. Four hundred 
thirty-three patients consented and provided data 
(Figure 2). 
The Active and Control groups were similar at 
baseline, except for the median number of subjects 
per PCP (6 in the Active group versus 15 in the 
Control group; p=0.045) (Table 1). Seven PCPs (22%) 
reported use of VisualDx prior to the study, 
including 4 (27%) in the Control group who agreed 
not to use it during the trial. 
Problem resolution 
Nearly half (48%) of all patients in the study 
considered their skin problem resolved (i.e., “all 
better”) by the final contact, including 46% in the 
Active group and 49% in the Control group (p=0.48). 
Active and Control patients were similar in terms of 
whether they were “all better,” “improved,” 
“unchanged,” or “worse” at their final interview 
(p=0.88) (Table 2, Figure 3). 
Figure 2 Flow of participants through stages of the randomized-cluster controlled trial 
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Table 1 Characteristics of primary care providers and patients 
 All Active Control p* 
Primary care providers n=32 n=17 n=15  
 n (%) n (%) n (%)  
Residents 13 (41%) 8 (47%) 5 (33%) 0.43 
Sex (male) 17 (53%) 10 (59%) 7 (47%) 0.49 
Family medicine (vs. internal 
medicine) 
14 (45%) 6 (35%) 8 (53%) 0.30 
 median (range) median (range) median (range)  
Year graduated 2010 (1976–2015) 2012 (1976–2015) 2002 (1977–2015) 0.44 
Study patients per provider 13.5 (1–34) 6 (1–32) 15 (1-34) 0.045 
 n (%) n (%) n (%)  
Used any CET ≥ 10 times in 
the prior month 
27 (84%) 13 (77%) 14 (93%) 0.19 
Used VisualDx in the prior 
month 
7 (22%) 3 (18%) 4 (27%) 0.54 
Patients n=433 n=158 n=275  
 median (range) median (range) median (range)  
Age in years, 431 obs. 58 (19–94) 58 (20–91) 58 (19–94) 0.73 
 n (%) n (%) n (%)  
Sex (male), 431 obs. 214 (49%) 77 (49%) 137 (50%) 0.54 
Completed all protocol 
interviews 
360 (83%) 126 (80%) 234 (85%) 0.15 
*p-value comparing Active and Control groups from χ2 tests for categorical variables (proportions) and Wilcoxon rank-sum tests for ordinal and 
continuous variables. 
 
Table 2 Problem resolution and return visit outcomes 
 All subjects Active Control p* 
Patients n=433 n=158 n=275 
 
 n (%) n (%) n (%)  
Final skin status       0.88 
Resolved 207 (48%) 72 (46%) 135 (49%)  
Improved 104 (24%) 41 (26%) 63 (23%)  
Unchanged 108 (25%) 40 (25%) 68 (25%)  
Worse 14 (3%) 5 (3%) 9 (3%)  





Return visits per patient 0.59 (1.07) 0.65 (1.10) 0.55 (1.05) 0.19 
 n (%) n (%) n (%)  
Any return visits (vs. none) 148 (34%) 59 (37%) 89 (32%) 0.29 
*p-value comparing Active and Control groups from χ2 tests for categorical variables (proportions) and Wilcoxon rank-sum test for number of visits. 
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Time to resolution was similar between groups 
throughout the observation period of up to 120 days 
(p=0.56 by log-rank test) (Figure 3). 
In univariable Cox proportional hazards 
models, with standard errors adjusted for provider 
clusters, the days from index visit to resolution were 
similar between groups (hazard ratio [HR]=0.92; 
95% confidence interval [CI]=0.70, 1.21; p=0.54). 
Tests for potential confounding by patient age and 
sex, PCP status (as resident and as patient’s regular 
provider), PCP time since graduation, number of 
patients per provider, and time of the year indicated 
no potential confounding. Therefore, these variables 
were not included in the analysis. 
Return appointments 
Active group patients had a mean of 0.65 return 
appointments compared to 0.55 in the Control group 
(p=0.19). The median was 0 return appointments in 
both groups (Figure 4). Thirty-seven percent of 
Active group patients had 1 or more follow-up 
appointments for the index problem, versus 32% of 
Control group patients (p=0.29). 
When analyzed as a binary variable (any follow-
up visits vs. none) in cluster-adjusted logistic 
regression, the odds of a return visit were higher in 
the Active group than in the Control group (odds 
ratio [OR]=1.25; 95% CI=0.93, 1.67; p=0.15), but this 
was not statistically significant. Tests for potential 
confounding by patient characteristics (age and sex), 
PCP characteristics (as resident, as patient’s regular 
provider, and time since graduation), or time of the 
year indicated no confounding. Therefore, these 
variables were not included in the model. However, 
the number of patients per provider was associated 
with the use of any follow-up visits (p=0.066) and 
group assignment (p=0.065), raising the possibility 
of confounding and warranting its inclusion in the 
final logistic regression model. The odds of any 
follow-up visits remained higher in the Active group 
than in the Control group, when adjusting for 
clustering and the number of patients per provider 
(OR=1.14; 95% CI=0.84, 1.56; p=0.39), but this was 
not statistically significant. The intra-cluster 
correlation coefficient for both outcome measures 
was <0.00001 with an upper 95% confidence limit of 
0.039. 
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Patients with skin problems whose PCPs used 
VisualDx experienced similar rates of problem 
resolution and similar time to resolution as patients 
whose providers did not use this CET. There was no 
difference in the number of follow-up visits to any 
health care provider for the index skin problem. 
The goal of this study was to assess the 
effectiveness of a CET as used in a generalizable 
clinical setting rather than to determine its 
mechanism of action or efficacy under ideal 
conditions. Therefore, we designed a “pragmatic 
trial” in a clinical environment in which day-to-day 
factors were not highly controlled. Pragmatic trials 
seek to answer the question, “Does this intervention 
work under usual conditions?” [23]. Intervention 
PCPs had flexibility in how they followed their 
assigned protocols to reference VisualDx when 
uncertainty about patient care arose. They could 
have searched in VisualDx by diagnosis terms, as 
opposed to using the differential diagnosis support 
tool. They could also have decided that assistance 
was not needed with some patients and opt not to 
employ the CET and could seek advice from 
additional sources after consulting VisualDx. 
We obtained data for the primary outcomes 
from patient reports because we sought to 
understand the outcomes of care as experienced by 
the patients. Patient-reported outcome measures 
complement other health care indicators such as 
provider-reported outcomes, chart review, and 
insurance data. They are appropriate measures in 
research when the intervention is incorporated into 
treatment [27, 28] and are frequently used in clinical 
trials of medical products, drugs, and health-related 
quality-of-life studies [29]. 
We did not evaluate whether the diagnosis or 
treatment that the PCP decided upon was correct by 
an objective standard, such as expert dermatologist 
review. Likewise, we did not distinguish 
appropriate follow-up appointments or referrals 
from unnecessary or avoidable ones, recording only 
that a follow-up occurred. 
Physician-reported benefits of referring to 
CETs—such as correct diagnosis, treatment, and 
avoidance of adverse events—have been previously 
noted. In a multi-institutional survey of physicians 
(n=4,906) and residents (n=1,290) in 118 hospitals, 
Marshall et al. found that 36% of physicians and 42% 
of residents changed a diagnosis after referring to a 
clinical evidence source in a recalled, recent incident. 
Physicians (29%) and residents (32%) also reported 
avoiding unnecessary procedures or tests because of 
the information that they used in the incident [5]. 
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Likewise, use of VisualDx may improve 
diagnostic skills. A team including the developer of 
VisualDx reported that among 28 cases initially 
misdiagnosed as cellulitis in the emergency room, 
VisualDx included the correct diagnosis in its 
differential diagnosis list more often than the 
admitting medical residents (64% vs. 14%; p=0.003). 
In a pilot study by Chou, clinical diagnoses of 13 
patients were made by 13 dermatology residents 
and 51 medical students before and after using 
VisualDx. Diagnostic accuracy increased from 63% 
to 81% (p<0.01) as judged by a consultant 
dermatologist [21]. Despite these positive 
intermediate effects, the published literature, 
including the study reported here, provides no 
evidence of better patient outcomes. 
Why did use of VisualDx—a technologically 
sophisticated, well-designed, state-of-the-art CET—
fail to influence the tested outcomes for skin 
disease? Some potential reasons for the negative 
results in this trial, such as bias due to uneven 
distribution of patient or provider characteristics, 
were minimized by the randomized design of the 
study. Another reason we found no difference 
between groups could be that the VisualDx users 
had insufficient knowledge of the resource to use it 
effectively. However, Active group PCPs were made 
aware of the resource, what it was meant to do, and 
how to access it. They received more training on its 
features, via an online tutorial, than is usually 
available in clinical practice. Although the VisualDx 
interface appears intuitive and easy to use compared 
to other CETs, it is possible that PCPs had difficulty 
finding the information that they needed. The 
specific content and interactive diagnosis tool of 
VisualDx, written largely by specialists, could be too 
complex or time consuming in the primary care 
setting. This may have contributed to busy clinicians 
bypassing VisualDx at times, resulting in 
suboptimal management. 
Even if the content acquired by the PCPs was 
correct from a biomedical point-of-view, the PCPs 
were not obligated to follow it. Indeed, local 
availability of certain procedures, prescriptions, and 
specialty referrals may make it unreasonable or 
impractical to follow the advice of the CET, 
potentially leading to the “no difference” result. 
Finally, it is possible that many skin problems 
presenting in primary care are inherently resistant to 
improvement no matter how well managed. They 
will resolve (or not) at their own pace regardless of 
the diagnosis and therapy offered. Nonetheless, 
return appointments and referrals to dermatology 
could conceivably be reduced with optimal primary 
care management. 
This study tested the effectiveness of VisualDx 
for problem resolution and return visit frequency, 
not for other outcomes such as improved diagnosis 
or satisfaction with care. This was not a 
comprehensive multi-attribute assessment of the 
CET. Likewise, ease of use and usefulness were also 
beyond the scope of this evaluation. 
As VisualDx is costly, this study may help 
health care organizations determine whether that 
cost is appropriate for their local institutional goals 
and settings. 
Strengths and limitations 
The randomized-cluster parallel design reduced the 
likelihood of bias due to differences in provider and 
patient subjects. Secular events occurring outside the 
study, such as seasonal changes in skin-related 
appointments, affected providers and patients in the 
intervention and control groups equally because of 
the randomized, parallel design. 
The study took place in one large academic 
medical center, possibly reducing generalizability to 
other settings. However, the patients of the study 
institution are similar to populations in rural regions 
of the United States in terms of age, race, poverty 
rates, and other factors. 
Although this was the largest randomized study 
of a CET with patient outcomes to date, the power to 
detect a potential effect was limited. Given the 
sample size of 433 patients, a control resolution rate 
of 49% within 90 days, and assumption of α=0.05, 
the study had 80% power to detect a resolution rate 
of at least 63% in the Active group, using χ2 analysis. 
The observed rate was 46% and, therefore, not 
significantly different from Control. In the Cox 
model, the observed HR of 0.92 (favoring Control) 
was well under the minimum detectable HR of 1.24. 
Likewise, the study had 80% power to detect a 
difference of 0.30 return visits per patient. The 
observed rate was 0.10 higher in the Active group. 
Given that all analyses showed a trend toward 
worse outcomes (i.e., longer time to resolution and 
more return visits in the Active group), it is highly 
unlikely that a larger study would have 
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demonstrated a statistically significant beneficial 
effect. 
The study relied on provider adherence to the 
protocol based on their agreement to do so (which 
was confirmed periodically). We did not have 
independent confirmation of their adherence. There 
might also have been contamination between 
provider subjects since there were both Active and 
Control providers in some clinics. While Active 
group PCPs used VisualDx as their primary 
resource for skin-related uncertainty and Control 
group PCPs did not, both groups could use other 
CETs and resources that were available in the 
information-rich environment of the academic 
medical center. This access could have masked a 
positive effect of using VisualDx. 
We had limited ability to independently 
measure participant usage of VisualDx prior to the 
study. However, at baseline, 22% of PCPs reported 
use of VisualDx in the prior month with no 
significant difference between groups. We did not 
measure VisualDx use during the study. 
Nevertheless, we did encourage provider adherence 
to the protocol. When contacted, all providers 
confirmed that they were staying within their 
assigned protocol of using or not using VisualDx as 
a reference. 
The study relied upon the memory of patients, 
which could have been faulty. However, the first 
patient interviews followed the index visit by 
approximately thirty days, which is a relatively 
short time span [25]. Only one patient who 
consented could not remember the skin problem 
visit at all. 
This study included patients with acute and 
chronic conditions reflecting the usual variety of 
skin conditions that are seen in primary care. It is 
possible that a study of only acute skin conditions or 
a study in an inpatient setting would have had a 
different outcome. 
Implications 
While VisualDx did not make a difference in the 
patient outcomes studied, it may have value for 
other goals such as medical knowledge, decision 
confirmation, and diagnostic confidence. The 
pragmatic study design with patient-level outcomes 
proved to be feasible and could be extended to 
evaluate other clinical evidence source technologies 
that are relevant to health care. 
CONCLUSION 
The study showed no difference in resolution of 
symptoms and return visits in patients of doctors 
who referenced VisualDx. Although VisualDx and 
other CETs can support institutional missions of 
medical knowledge and practice improvement, 
VisualDx does not appear to improve patient 
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